Cure of Experimental Human Malignant Mesothelioma in Athymic Mice by Diphtheria Toxin
- 19 April 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 81 (8) , 622-627
- https://doi.org/10.1093/jnci/81.8.622
Abstract
A single ip or iv dose of 1–3 μg of diphtheria toxin consistently cured athyniic mice of an advanced stage experimental human malignant mesotheioma. All cancer cells were killed within 18 hours and the profuse ip ascites plus large solid tumor masses associated with this model of neoplastic disease were subsequently eliminated. Treated mice appeared normal in 3 days and lived for >300 days with no signs of recurrence, while control animals did not survive >32 days. The complete tumoricidal effect implies that toxin readily reached, entered, and preferentially killed each human cancer cell. This outcome exemplifies the true therapeutic potential of highly selective, site-directed toxins, and offers a frame of reference for judging the performance of current as well as prospective toxin-based agents. [J Natl Cancer Inst 81:622–627, 1989]This publication has 2 references indexed in Scilit:
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- High specific cytotoxicity of antibody-toxin hybrid molecules (immunotoxins) for target cellsImmunology Letters, 1980